The acquisition was completed on October 5, according to Marico’s regulatory filing.
Marico had earlier acquired a 60% stake in Satiya Nutraceuticals and had the right to buy the remaining shares under definitive agreements.
The company has now agreed to acquire the remaining 38.18% stake held by the founders and certain other shareholders in tranches. The latest transaction takes its holding to 84.09%, while the remaining 14.09% is expected to be acquired in July 2027, subject to the terms of the agreements.
Marico’s aggregate consideration for the 84.09% stake will be ₹1,392.07 crore.
The consideration for the remaining 14.09% stake will be determined at the time of acquisition and will comprise a base consideration of up to ₹592 crore, along with additional payments linked to milestones and other terms under the agreements.
Satiya Nutraceuticals operates in the health, wellness and personal care segment and has Juizo Advisory as its wholly owned subsidiary.
Marico said the investment expands its addressable market in value-added foods and nutrition while strengthening its presence in personal care and wellness.
The acquisition of shares from the founders and their relatives or related entities constitutes related-party transactions and has been carried out on an arm’s-length basis, Marico said. The company’s promoter and promoter group have no interest in the transaction, it added.
The acquisition does not require any government or regulatory approvals.
Marico sees strong Q2 momentum
Separately, Marico said on Monday that it expects to surpass its near-term guidance across key financial parameters, helped by the strength of its core brands and the growth of newer businesses.
The company’s India business delivered another strong quarter, with underlying volume growth reaching double digits, according to its quarterly business update.
Parachute Coconut Oil sustained its strong performance, with volume growth in the early teens. Saffola Oil recorded mid-single-digit price-led growth, although volumes declined as Marico focused on maintaining profitability and reduced supplies of select variants.
Also Read: India’s global equity market share falls below 3% as foreign outflows rise